Evidence map›Paper›PMID 41184413›Full record

ArticleScientific reports2025

Adsorptive removal of pimavanserin from water using β-cyclodextrin polymer coated PVDF nanofibers.

Mohamed Magdi Ahmed, Christopher J Hobbs, Anna Maria Schmidt, Michal Řezanka

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed Magdi AhmedFaculty of Mechatronics, Informatics and Interdisciplinary Studies, Technical University of Liberec, Studentská 1402/2, 461 17, Liberec, Czech Republic.ORCID http://orcid.org/0000-0002-3808-8912
Christopher J HobbsInstitute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Studentská 1402/2, 461 17, Liberec, Czech Republic.ORCID http://orcid.org/0000-0002-5456-5301
Anna Maria SchmidtDepartment of Chemistry and Technology of Functional Materials, Faculty of Chemistry, Gdańsk University of Technology, 11/12 Narutowicza Street, 80-233, Gdańsk, Poland.
Michal ŘezankaInstitute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Studentská 1402/2, 461 17, Liberec, Czech Republic. michal.rezanka@tul.cz.ORCID http://orcid.org/0000-0002-7390-1243

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy CZ.02.1.01/0.0/0.0/16_019/0000843Ministerstvo Školství, Mládeže a Tělovýchovy LM2023066Technická Univerzita v Liberci SGS-2021-4026
6 · The paper itself

Abstract

In this study, we present the synthesis of polyvinylidene fluoride (PVDF) nanofibers functionalized with an acrylic-β-cyclodextrin (β-CD-Acr) polymer as advanced adsorptive material for pharmaceutical removal from water. The modified nanofibers (NFs) demonstrated superior adsorption performance towards the model compound pimavanserin, with an equilibrium adsorption capacity of 56.2 mg/g compared to 34.2 mg/g for the β-CD-Acr polymer alone. The maximum uptake capacity also nearly doubled (113.6 mg/g vs. to 54.8 mg/g) highlighting the benefits of using the nanofiber support. The versatility of this polymer allows it to be polymerized onto various substrates, making it a promising candidate for large-scale applications. The results suggest that this innovative adsorptive nanofiber system could play a crucial role in combating water pollution globally, offering an effective and scalable solution for the removal of hazardous pharmaceuticals from wastewater.

Indexed as

AdsorptionCyclodextrin polymersNanofibersPharmaceutical pollutantsSurface functionalizationWater treatment

Identifiers

PMID41184413
PMCPMC12583664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.